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Taeyeumjoweetang (TYJWT) is a herbal medication that was mentioned in Jema Lee’s
Donguisusebowon, which is a book about Sasang constitutional medicine. Tae-eumnis, one of
the four constitutions, tend to suffer from metabolic diseases such as obesity and diabetes. It is
widely used to treat the digestive problems and obesity of Tae-eumins. We divided mice that were
fed a normal diet for 48 days into control, TYJWT 250mgkg
 1 and TYJWT 500mgkg
 1
groups. After carrying out the experiments, the serum levels of leptin, adiponectin, ghrelin and
resistin were measured. The results showed that TYJWT significantly reduced the weights of
mice that were fed a normal diet, and that this was due to a decrease in food intake. Also, the two
TYJWT groups had lower serum levels of leptin compared to the control group, and the ghrelin
levels were proportionately increased by the dosage of TYJWT given. These results show that
TYJWT has obesity-suppressing effects similar to those previously reported using high fat diets.
In addition, these results also provide evidence that TYJWT has anti-obesity effects.
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Introduction
Taeyeumjoweetang (TWJWT) was first mentioned by
Jema Lee (1837–1900) in Donguisusebowon as a herbal
medication consisting of eight herbs, which is used to
treat ‘exterior-cold disease by cold in the esophagus’ of
Tae-eumin (1). To date, research on the anti-obesity
effects of TYJWT showed that it suppressed the weights
and serum lipid profiles of obese mice induced by a high-
fat diet (2), its herbal acupuncture form improved the
high-fat-diet-induced lipid profiles of serum and the
liver (3) and that it suppressed leptin gene expression in
obese mice (4).
Obesity is a chronic metabolic disorder caused by an
imbalance between energy intake and usage, and is char-
acterized by weight gain due to an increase in body fat
and serum lipid content (5,6). Recent research shows that
several substances are secreted by adipose cells that either
cause or improve obesity. Among these, leptin and resis-
tin are important factors that control weight, although
their exact roles have not yet been defined (7). Ghrelin
is secreted by the stomach (8) and its synthesis and secre-
tion are primarily controlled by changes in body energy.
Its secretion is increased when the energy level is low and
secretion decreases when the energy level is high (9).
Ghrelin expression is also controlled by leptin (10).
To date, research into the anti-obesity effects of
TYJWT have used obese animal models that were
induced by a high-fat diet (2–4). TYJWT has been
widely used for treatment of Tae-eumins’ obesity in
Korea. In order to closely approach the clinical
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properly cited.condition, we explored the effects of TYJWT on
mice that were fed a normal diet. For 48 days, we mea-
sured the weights and food intakes of mice that were
given 250 and 500mgkg
 1 doses of TYJWT, as well as
the levels of serum leptin, resistin, ghrelin and
adiponectin.
Methods
Test Animals
We purchased 30 C57BL/6J male mice (20–25g) that
were 3 weeks old from Central Lab. Animal Inc. The
mice were adapted to the test environment by being fed
standard experiment diet for 1 week. The mice were
raised in a controlled environment (temperature at
20 C, 50% humidity, light cycle from 06:00 to 18:00
hours and dark cycle from 18:00 to 06:00 hours), and
during the experiment they were allowed to drink water
freely. All these procedures involving the use of animals
have been conducted in agreement with NIH Guidelines
and approved by the Animal Use and Care Committee of
Wonkwang University.
TYJWT Extraction Method
After purchasing TYJWT (Table 1) from Wonkwang
Oriental Medical Hospital, it was certified by the Depart-
ment of Herbology, College of Oriental Medicine,
Wonkwang University before use. TYJWT (200g) was
placed in a round bottom flask with 1.8l of triple distilled
water. After attaching a freezer, it was boiled for 3h,
centrifuged at 3000rpm for 20min, decompressed and
concentrated using a rotating vacuum concentrator.
Using a freeze drying machine, 31.3g of powder was
obtained. This was stored at  70 C until used in
experiments.
Test Groups
The mice were divided into three groups and were fed for
48 days as follows. The control group was fed a normal
diet and was given saline twice daily. The TYJWT groups
were given oral doses of 250 and 500mgkg
 1 twice daily,
at 09:00 and 21:00 hours. Weights and food intakes
were measured every 4 days. After this period, the mice
were decapitated, serum was separated, and separated
epididymal fat and stomach were stored at  70 C until
assayed.
ELISA
Serum concentrations for leptin, adiponectin, ghrelin
and resistin were measured using ELISA kits (Roche
Diagnostics, CA, USA) according to the manufacturer’s
protocols.
RNA Extraction
The extraction of total RNA from the stomach and
fat tissues used Trizol reagent (Life Technologies, UK)
according to the manufacturer’s protocols. Tissue
(100mg) was cut into pieces, dissolved in 500ml
RNAzol B, 50ml chloroform was added, and the reaction
was run for 5min on ice. After the reaction, samples were
centrifuged at 15700g at 4 C for 20min, and then
the upper layer was put in a new tube. An equal
volume of isopropanol was added to the upper layer,
and the reaction was run for 30min. After the reaction,
samples were centrifuged at 15700g at 4 C for 20min,
and then the sediments were cleansed with 80% EtOH.
The cleansed RNA was dried, melted with 20 of DEPC-
treated water and the optical density was quantified using
a spectrophotometer.
Real-Time Reverse Transcription Polymerase
Chain Reaction
Reverse transcription reactions used 3–5mg total RNA
and reverse transcriptase (MMLV; Invitrogen, Carlsbad,
CA) according to the manufacturer’s protocol. The reac-
tion used a reaction solution of total RNA (3–5mg), oligo
d (T) 12–18 (1mg), 2ml dNTP (10mM), MMLV reverse
transcriptase (200U), DTT (10mM), RNase inhibitor
(1ml; Promega, USA) and a 20ml buffer solution
(50mM Tris–Cl, pH 8.3, 75mM KCl, 3mM MgCl2)
at 42 C for 60min, after which cDNA was synthesized.
Real-time reverse transcription polymerase chain reaction
was done by mixing cDNA (diluted 10 times) with 2 
SYBR-Green buffer solution (Roche Diagnostics Ltd,
UK), which contained reverse transcription enzymes,
using a LightCycler rapid thermal cycler system
(Roche). In summary, after letting the reaction mixture
react at 95 C for 10min, 45 cycles of denaturation
(95 C 10s), annealing (58 C for leptin, ghrelin or 60 C
for b-actin, 5s) and elongation (72 C 10s) were done.
The expressed leptin and ghrelin concentrations were
calculated relative to the amount of b-actin using
Table 1. Composition of TYJWT
Herbal name Scientific name Amount (g)
Semen Coicis 11.25
Castanea Mollisima 11.25
Semen Raphani 7.5
Fructus Schizandrae 3.75
Radix Ophiopogonis 3.75
Rhizoma Acori Graminei 3.75
Radix Platycodi 3.75
Heraba Ephedrae 3.75
Total amount 48.75
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leptin, ghrelin and b-actin are shown in Table 2.
Statistical Analysis
Test results were expressed as mean SEM. Group com-
parisons used a one-way ANOVA test (Microcal Origin;
version6.0; Microsoft, USA), with P50.05 considered
statistically significant.
Results
Decrease of Body Weight
In order to explore the effects of TYJWT on weight
changes of normal mice, 250 and 500mgkg
 1 oral
doses of TYJWT were given for 48 days, and weight
changes were measured every 4 days. As shown in
Fig. 1, the control group mice, which were fed a
normal diet, showed significant weight gains as time
passed. However, the TYJWT groups showed significant
weight losses compared to the control group starting at
Day 36, and the weight loss effects in the 250mgkg
 1
group was more pronounced than the 500mgkg
 1
group (Fig. 1). Regarding food intake, starting at Day
36, the TYJWT groups ate less compared to the control
group (Fig. 2).
Changes in Leptin and Ghrelin Expression
In order to find a relationship between the weight loss
effects of TYJWT and appetite, we examined the serum
levels of leptin and ghrelin, as well as their mRNA
expressions in the fat and stomach tissues (Fig. 3). The
results showed that the 500mgkg
 1 TYJWT group
secreted significantly less leptin into the bloodstream
compared to the control group, and the expression of
leptin mRNA in fat tissue also coincided with this
result. By comparison, the levels of ghrelin secreted into
the serum as well as the expression of mRNA in the
stomach tissue were proportionate to the dosage of
TYJWT given.
Reduction in Secretions of Adiponectin and Resistin
In order to examine a weight loss mechanism for
TYJWT, the levels of adiponectin and resistin secreted
into the serum were measured (Fig. 4). The adiponectin
levels of the two TYJWT groups were not significantly
different from one another, but TYJWT reduced the
amounts of resistin secreted into the bloodstream in a
dose-dependent manner.
Discussion
Obesity is a metabolic disorder caused by excess energy
intake relative to energy usage and is a state in which the
supply of energy is so excessive that the remainder of
energy accumulates in the body (11,12). Because obesity
Figure 1. Effects of TYJWT on body weight changes in mice. Control:
normal diet group, n¼10; TYJWT (250): normal dietþ250mgkg
 1
TYJWT extract; TYJWT (500): normal dietþ500mgkg
 1 TYJWT
extracts. Values are mean SEM. *P50.05 versus control.
Figure 2. Effects of TYJWT on food intake in mice.
Table 2. Sequences and accession numbers for primers used for real-
time PCR
Gene Sequence for Primers (50!30) Accession no.
b-Actin Forward: gtgctatgttgctctagact NM 007393
Reverse: cacaggattccatacccaag
Leptin Forward: caggatcaatgacatttcacaca NM 008493
Reverse: gctggtgaggacctgttgat
Ghrelin Forward: ccagaggacagaggacaagc NM 021488
Reverse: catcgaagggagcattgaac
eCAM 2009;6(S1) 83is strongly associated with depression, diabetes, hyperten-
sion, hyperlipidemia, coronary heart disease and arthritis,
there have been numerous efforts to prevent and treat
obesity. However, most medications used have significant
side effects as well as hepatotoxicity, so their long-term
use is impossible. And long-term medications that have
been approved by the FDA, such as orlistat (Xenical)
and sibutramine (Reductil), have been shown to suppress
fat accumulation and induce weight loss, but have side
effects like oily stool, physconia, undurable stool, head-
ache, constipation, thirst, nausea, dizziness and insomnia
(13,14). Therefore, research into herbal medications,
which have been proven to have fewer side effects than
these medications, is needed.
TYJWT is the most widely used clinical anti-obesity
herbal medication. Although it has been reported on its
positive effects for obesity many times (2–4), its anti-
obesity mechanism has not yet been clarified. Tests that
examined the anti-obesity effects of TYJWT have mainly
used obese animal models that were induced by a high fat
diet (2–4). In contrast, our research examined the effects
of TYJWT on mice that were fed a normal diet. TYJWT
extract significantly reduced the weight gains caused by
a normal diet (Figs 1 and 2). Furthermore, TYJWT
suppressed slightly fat accumulation in the epididymal
fat pad (data not shown) without suppressing feed
intake, which led to a decrease in the body weight gain.
These results indirectly suggest that TYJWT decreases
weight gain not only by reducing fat mass but also by
reducing lean body mass. Therefore, further study is
required to clarify the possible metabolic effect of
TYJWT on lean body mass.
Generally, leptin is secreted by fat tissues and con-
trolled by neuropeptide Y from the thalamus, which
reduces food intake and suppresses weight gain (15).
But, when its secretion is excessive, or when leptin expos-
ure is prolonged, it accelerates lipolysis and increases
energy use (16). The lower leptin concentration observed
in the serum of TYJWT-treated mice could not be related
to the improvement of metabolic changes, such as the
lipid-lowering effect of TYJWT. Considering the current
state of research into the role of leptin in obesity and
obesity-related genes, more research is needed.
In contrast to the appetite-suppressing effects of leptin,
ghrelin, which is secreted by the stomach, increases
appetite. Ghrelin has been shown to be controlled by
Figure 3. Effects of TYJWT on leptin and ghrelin expressions in mice. Leptin and ghrelin concentrations in plasma were measured by ELISA;
mRNA levels were measured by the real-time PCR assay as described in the ‘Methods’ section. Values are mean SEM. *P50.05 versus control.
84 Anti-obesity effects of Taeyeumjoweetangthe body’s energy levels, as its levels increase during
hunger and decrease when food is eaten (9). Leptin, insu-
lin and somatostatin have been reported to be affected by
the secretion of ghrelin in the stomach (9,10,17). In our
tests, the 500mgkg
 1 TYJWT group showed reduced
leptin expression compared to the control group. But,
the levels of ghrelin increased proportionately to the
dosage of TYJWT given. According to research on the
effects of leptin and ghrelin on appetite and weight (9,17),
TYJWT extract increased appetite and weight, yet in
our tests, TYJWT extract resulted in reduced weight.
According to Toshinai (18), when leptin was given to
mice for 5 days, the ghrelin mRNA levels increased.
However, Asakawa et al. (9) reported that leptin
decreased the expression of ghrelin. Initial reports
showed that leptin is secreted by fat tissues (19), but it
is now known that it is also secreted from various tissues,
including the stomach (20). The possibility that the
leptin-reducing effect of TYJWT is due to its influence
on leptin expression and secretion by other tissues besides
fat tissue cannot be excluded, and further research
is necessary. Also, we conclude that leptin influences
the expression of ghrelin in the stomach.
Recently, fat tissue has been found not only to store fat
but also to secrete adipocytokines, such as adiponectin,
leptin and TNF-a. Recent research shows that serum
adiponectin levels are lower in obesity that is accompa-
nied by type 2 diabetes (21). Resistin increases insulin
resistance and fat synthesis. Thus, in resistin knock-
out mice, glucose intolerance was improved and fat syn-
thesis was suppressed in the fat tissues (22). As shown in
Fig. 4, TYJWT extract did not influence the serum adi-
ponectin levels, but it did reduce the resistin levels
inversely according to the dosage. We can analogize
that TYJWT extract lowers weight by suppressing fat
synthesis due to decreased food intake, but the lipolysis
effects of TYJWT cannot be excluded.
In our tests, TYJWT reduced the weights of mice that
were fed a normal diet. Along with previous results show-
ing that TYJWT extract suppressed obesity in high-fat-
diet-fed mice (2–4), these results will be a basis for the
development of TYJWT as an anti-obesity medication.
For the future, more detailed research into the mecha-
nisms of TYJWT’s anti-obesity effects must be done.
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